Finally, our findings, together with the urinary excretion of hepcidin43, offer the possibility that hepcidin can serve a diagnostic indicator for liver fibrosis and/or can determine the prognosis of fibrosis disease progression as a non-invasive biomarker. This evidence concerns the gene HAMP and Hepatic fibrosis.